These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12848263)

  • 21. Thyrotoxicosis in Sierra Leone: diagnosis and treatment with radioactive iodine (131I).
    Knox-Macaulay HH
    Trop Geogr Med; 1982 Jun; 34(2):169-75. PubMed ID: 7123649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome of Graves' disease patients treated in a region with iodine deficiency: relapse rate increases in years with thionamides.
    Tütüncü NB; Tütüncü T; Ozgen A; Erbas T
    J Natl Med Assoc; 2006 Jun; 98(6):926-30. PubMed ID: 16775915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experience in the use of radioactive iodine therapy for hyperthyroidism in Nigerian patients. A study of twenty-two patients.
    Agboola-Abu CF; Kuku SF
    West Afr J Med; 2003 Dec; 22(4):324-8. PubMed ID: 15008298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of radiation doses received by the public from 131I treatment of thyrotoxic outpatients.
    Wasserman HJ; Klopper JF
    Nucl Med Commun; 1993 Sep; 14(9):756-60. PubMed ID: 8233240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of amiodarone-induced thyrotoxicosis.
    Osman F; Franklyn JA; Sheppard MC; Gammage MD
    Circulation; 2002 Mar; 105(11):1275-7. PubMed ID: 11901034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting outcomes and complications following radioiodine therapy in Graves' thyrotoxicosis.
    Aung ET; Zammitt NN; Dover AR; Strachan MWJ; Seckl JR; Gibb FW
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):192-199. PubMed ID: 30291728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Late results of treating thyrotoxicosis with 131I and post-therapeutic hypothyroidism].
    Khelds AO; Ozols VK; Shtelmane IA
    Med Radiol (Mosk); 1986 Mar; 31(3):24-7. PubMed ID: 2421127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperthyroidism and hypothyroidism complicating the treatment of thyrotoxicosis.
    Reid DJ
    Br J Surg; 1987 Nov; 74(11):1060-2. PubMed ID: 2446693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre.
    Le Moli R; Wesche MF; Tiel-Van Buul MM; Wiersinga WM
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):783-9. PubMed ID: 10468951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of low and high 131I doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma based on post-operative cervical uptake.
    Rosário PW; Reis JS; Barroso AL; Rezende LL; Padrão EL; Fagundes TA
    Nucl Med Commun; 2004 Nov; 25(11):1077-81. PubMed ID: 15577584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation dose rates from adult patients receiving 131I therapy for thyrotoxicosis.
    O'Doherty MJ; Kettle AG; Eustance CN; Mountford PJ; Coakley AJ
    Nucl Med Commun; 1993 Mar; 14(3):160-8. PubMed ID: 8455905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of long-term follow-up after compensated fixed-dose therapy for thyrotoxicosis.
    Zaini A; Khir A; Doi SA; Chan SP; Paramsothy M; Khoo BH
    J Int Med Res; 1992 Jun; 20(3):279-88. PubMed ID: 1397673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioiodine treatment of Graves' disease - dose/response analysis.
    Cepková J; Horáček J; Vižďa J; Doležal J
    Acta Medica (Hradec Kralove); 2014; 57(2):49-55. PubMed ID: 25257150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of treatment of hyperthyroidism.
    Bringmann IM; van Leeuwen BL; Hennemann G; Beckett GJ; Toft AD
    J Endocrinol Invest; 1999 Apr; 22(4):250-6. PubMed ID: 10342357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of 131I therapy in hyperthyroidism using a 550MBq fixed dose regimen.
    Lewis A; Atkinson B; Bell P; Courtney H; McCance D; Mullan K; Hunter S
    Ulster Med J; 2013 May; 82(2):85-8. PubMed ID: 24082285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules.
    Nygaard B; Hegedüs L; Nielsen KG; Ulriksen P; Hansen JM
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):197-202. PubMed ID: 10396362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful radioiodine treatment in a 3 year old child with Graves' disease following antithyroid medication induced neutropenia.
    Rahman MA; Birrell G; Stewart H; Lucraft H; Cheetham TD
    Arch Dis Child; 2003 Feb; 88(2):158-9. PubMed ID: 12538324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Standard dose 131I therapy for toxic multinodular goiter in an endemic goiter region.
    Gonçalves E; Castro JA; Gross JL
    Braz J Med Biol Res; 1986; 19(6):723-9. PubMed ID: 3651625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Audit of long-term treatment outcomes of thyrotoxicosis in a single-centre virtual clinic: The utility of long-term antithyroid drugs.
    Levy MJ; Reddy N; Price D; Bhake R; Bremner E; Barrowcliffe M; Kieffer V; Robinson C; Zaccardi F; Howlett TA
    Clin Endocrinol (Oxf); 2022 Nov; 97(5):643-653. PubMed ID: 35274339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between low and high radioactive iodine (131I) reablation dose in patients with papillary thyroid cancer.
    M El-Refaei S; W Yassin S; Salman K; Al Munshy T; Al-Ezzi M; M Al-Sayed Y; Abd Elkareem Husseni M
    Nucl Med Commun; 2015 Feb; 36(2):114-9. PubMed ID: 25350460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.